Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial.
Saved in:
| Title: | Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial. |
|---|---|
| Authors: | Betts, Joanna C.1, Mayer, Ruth J.2, Tal ‐ Singer, Ruth2, Warnock, Linda1, Clayton, Chris1, Bates, Stewart1, Hoffman, Bryan E.2, Larminie, Christopher1, Singh, Dave3 |
| Source: | Pharmacology Research & Perspectives. Feb2015, Vol. 3 Issue 1, pn/a-N.PAG. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
